FDA Inspection 1210565 — 96Th Medical Group Blood Transfusion Services

96Th Medical Group Blood Transfusion Services — FEI 1052138

The FDA completed an inspection of 96Th Medical Group Blood Transfusion Services on Jun 6, 2023 in Eglin Afb, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 6, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Eglin Afb, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.